Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery Platform
Sponsor : GPCR Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration
AbTherx and GPCR Therapeutics Partner to Develop Antibody Therapies for GPCRs
Details : The collaboration aims to discover and develop therapeutic antibodies targeting G protein-coupled receptors (GPCRs) for one target, with the potential to expand to additional targets.
Product Name : Undisclosed
Product Type : Antibody
Upfront Cash : Undisclosed
June 16, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery Platform
Sponsor : GPCR Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Discovery Platform
Recipient : Vaccinex
Deal Size : Undisclosed
Deal Type : Collaboration
AbTherx, SCT, and Vaccinex Join Forces on Hard-to-Target Antibody Drugs
Details : AbTherx and Single Cell Technology will incorporate Vaccinex's ActivMAb® Technology into their respective workflows for complex drug targets.
Product Name : Undisclosed
Product Type : Antibody
Upfront Cash : Undisclosed
May 13, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery Platform
Recipient : Vaccinex
Deal Size : Undisclosed
Deal Type : Collaboration
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery Platform
Sponsor : Spice Biotechnologies
Deal Size : Undisclosed
Deal Type : Collaboration
AbTherx and Spice Biotechnologies Announce Multi-Program Antibody Discovery Collaboration
Details : The partnership will leverage AbTherx's suite of innovative Atlas Mouse technologies to deliver antibodies against targets selected by Spice Bio.
Product Name : Undisclosed
Product Type : Antibody
Upfront Cash : Undisclosed
May 12, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery Platform
Sponsor : Spice Biotechnologies
Deal Size : Undisclosed
Deal Type : Collaboration
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Discovery Platform
Sponsor : Rondo Therapeutics
Deal Size : Undisclosed
Deal Type : Licensing Agreement
AbTherx and Rondo Therapeutics Announce Multi-Program Antibody Discovery Collaboration
Details : Under the terms of the licensing agreement, Rondo has the right to develop and commercialize therapeutic antibodies resulting from the collaboration.
Product Name : Undisclosed
Product Type : Antibody
Upfront Cash : Undisclosed
April 23, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery Platform
Sponsor : Rondo Therapeutics
Deal Size : Undisclosed
Deal Type : Licensing Agreement